Monitoring Patients for Developing Communicable and Opportunistic Infections and for Responding to Therapy

Completed

Conditions studied: Communicable Diseases, Opportunistic Infections

In brief

Patients are exposed to infectious agents regularly, regardless of their immunologic status. Traditionally clinicians have decided to institute prophylaxis based on epidemiologic factors, skin test (i.e. PPD), or immunologic parameters. A quantitative and specific method that is non-invasive, such as quantitative PCR, would be desirable to more precisely define those who would benefit from prophylaxis. Similarly, when patients develop disease and are being treated, quantitative, non-invasive techniques are needed to assess response to therapy. This project is designed to develop and test quantitative tests using blood, urine, or sputum samples.

Key facts

Study ID
NCT00001477
Run by
National Institute of Allergy and Infectious Diseases (NIAID)
People needed
300
Starts
1995-08-01
Expected to finish
2000-10-01
Last updated by the study team
2008-03-04

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.